NIH Retires Business-System Privacy Notice; Your Records Stay Put
Published Date: 11/12/2026
Notice
Summary
The NIH is retiring an old privacy notice for its Business System because the same info is now protected under newer, broader rules. This change affects anyone whose data is in the NIH Business System Cloud, but don’t worry—the records are still safe and managed properly. The update takes effect immediately with no extra costs involved.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22871, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for eye disease, neuronal injury, infectious diseases, and related projects. No public access is allowed to protect private info and trade secrets, but these reviews help decide who gets research money.
2026-22558, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for health-related projects, ensuring privacy for sensitive information. No direct money changes are announced, but these reviews help decide who gets research grants.
2026-22550, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding two closed virtual meetings on November 30, 2026, to review important grant applications. These meetings affect researchers applying for funding in cardiovascular sciences and tobacco regulatory science. No public access is allowed to protect private info and trade secrets, and the reviews help decide who gets research money.
2026-22339, Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human
The National Institutes of Health plans to give AntaraCore Systems, Inc. an exclusive license to use new catheter technology that treats dangerous heart rhythm problems called ventricular arrhythmia. This means AntaraCore will have special rights to develop and sell this life-saving treatment. If you want to comment or apply for a license, you must do so by December 2, 2026.
2026-22196, National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a public meeting on May 12, 2027, to discuss important council business and review grant applications. People interested can attend in person or online, but space is limited and some parts of the meeting will be private to protect sensitive information. This meeting affects researchers and organizations seeking funding and sets the stage for future diabetes and kidney disease research support.
2026-22114, Fogarty International Center; Notice of Meeting
The Fogarty International Center Advisory Board is meeting on June 7, 2027, both in-person and online to share updates and review important grant applications. This meeting affects researchers and organizations applying for funding, with some sessions open to the public and others closed to protect privacy and trade secrets. No registration is needed to join the open session, making it easy to stay informed about global health research funding.
Previous / Next Documents
Previous: 2026-23006, Importer of Controlled Substances Application: NSI Lab Solutions LLC
NSI Lab Solutions LLC wants to become an official importer of certain controlled substances, like Amineptine and Mesocarb. People who make or use these drugs can share their thoughts or ask for a hearing by December 14, 2026. This move could affect companies handling these substances and involves a formal review process with no immediate cost changes announced.
Next: 2026-23009, Notice of OFAC Sanctions Action
The U.S. Treasury’s OFAC just blocked the assets of certain companies linked to Iran’s digital currency sector, including 1380079 BC LTD and 2397639 ONTARIO LTD. From November 6, 2026, Americans can’t do business with these firms, freezing their U.S.-based property and interests. This move aims to tighten the financial squeeze on Iran’s economy and warns others about the risks of dealing with these entities.